Fluorouracil

This classification denotes a thymidylate synthase inhibitor and pyrimidine antagonist with the molecular formula C4H3FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U3P01618RT, chemically known as 2,4-dioxo-5-fluoropyrimidine but more generally known as fluorouracil, which bears U.S. National Institutes of Health Compound Identifier 3385. The European Medicines Agency schedules Fluorouracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07721MIG. The term FLUOROURACIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). The World Health Organization schedules fluorouracil in its Anatomical Therapeutic Chemical (ATC) Classification. FLUOROURACIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Fluorouracil under HS 29335995. SMILES: FC1C(=O)[NH]C(=O)[NH]C1.